Publications & Works

Articles Published in Journals That Entered SCI, SSCI and AHCI Indexes

Evaluation of Cytotoxicity and Mutagenicity of Wastewater from Istanbul: Data from Hospitals and Advanced Wastewater Treatment Plant

BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, vol.104, no.6, pp.852-857, 2020 (Journal Indexed in SCI) identifier identifier identifier

Thiols, malonaldehyde status in the Turkish and total antioxidant patients with type 2 diabetes mellitus

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, vol.201, no.3, pp.147-155, 2003 (Journal Indexed in SCI) Creative Commons License identifier identifier identifier

Articles Published in Other Journals

Obezitede Ran Geni Anlatımının Adipogenez ile İlişkisinin Araştırılması

İSTANBUL BİLİM ÜNİVERSİTESİ FLORENCE NIGHTINGALE TIP DERGİSİ, vol.2, no.3, pp.201-207, 2016 (Other Refereed National Journals)

KişininGenetik Yapısına Özel Bireysel İlaç Tedavileri Farmakogenetik

Yeni Türkiye Dergisi Bilim ve Teknoloji Özel Sayısı III, 2016 (Other Refereed National Journals)

Histopothological Effects of Fluoxetine on Zebra Fish Danino Rerio Gills

Elixir Applied Zoology, vol.89, pp.36709-36711, 2015 (Refereed Journals of Other Institutions)

Refereed Congress / Symposium Publications in Proceedings

Tramadol: From CYP2D6 Pharmacogenetic Testing To Clinical Dat

5th ESPT Congress Precısıon Medıcıne and Personalised Health, Sevilla, Spain, 16 - 18 October 2019

Implementation of Pharmacogenetics in Turkish Clinical Practice:Challenges and Opportunities

International Congress on Biological and Medical Sciences 2018, 31 October - 03 November 2018

Implementatıon Of Pharmacogenetics In Turkish Clinical Practice: The Example Of Dihydropyrimidine Dehydrogenase

The 9 th Santorini Conference “Systems medicine and Personalised Health and Therapy”: The Odyssey from Hope to Practice, Santorini, Greece, 30 September - 03 October 2018

Pharmacogenetics Of Clopidogrel In Coronary Artery Disease Patients: Results From Turkish Clinical Practice

The 9th Santorını Conference Systems Medıcıne and Personalısed Health Therapy « The Odyssey From Hope To Practice », Santorini, Greece, 30 September - 03 October 2018

Pharmacogenetics: Implementing Personalized Medicine in Turkish Clinical Practice

IV. Intenational Congress on Applied Biological Sciences, 3 - 05 May 2018

Role of genetics in the selection of surgical methods and its use as a primary treatment

Congress for the surgery of obesity and metabolic disorders, 12 - 15 October 2017

Investigation Of The Effects Of Clopidogrel In AML12 Hepatocyte Cell Line Over Lysosomal Activity

5 th National amp 3 rd Mediterranean Congres for the Surgery of Obesity and Metabolic Dersorders, Antalya, Turkey, 12 - 15 October 2017

The Effects of Clopidogrel on CD68 Gene Expression in Adipocyte, Hepatocyte Cell Lines and Co-cultures

5th National 3rd Mediterranean Congress for the Surgery of Obesity and Metabolic Disorders, Antalya, Turkey, 12 - 15 October 2017

Investigation of the Effects of Clopidogrel in AML Hepatocyte Cell Line Over Membrane Integrity

5 th National amp 3 rd Mediterranean Congres for the Surgery of Obesity and Metabolic Dersorders, Antalya, Turkey, 12 - 15 October 2017

Investigation Of The Effects Of Clopidogrel In AML12 Hepatocyte Cell Line Over Mitochondrial Activity. Mitochondrial Activity

5 th National amp 3 rd Mediterranean Congres for the Surgery of Obesity and Metabolic Dersorders, Antalya, Turkey, 12 - 15 October 2017

Association Of CYP2C19 Gene rs4244285 Polymorphism With Clinical Cardiovascular Events In Patients Using Clopidogrel

4 th ESPT Conference. Pharmacogenomics and Personalised Medicine: research progress and clinical implementation, Catalunya, Spain, 4 - 07 October 2017

Investigation Of CYP2C9 2 Polymorphism In Patients With Cardiovascular Disease Using Warfarin

4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation, Catalunya, Spain, 4 - 07 October 2017

The Effects of Clopidogrel on DNA damage in Adipocyte and Hepatocyte Cell Lines

4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation, Catalunya, Spain, 4 - 07 October 2017

Genetic Polymorphisms of CYP3A4 1B In Patients With Coronary Artery Disease Using Statin

4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation, KATANYA, Italy, 4 - 07 October 2017

National drug applications to ındividiual specific genetic structure:Pharmacogenetics

Innovation in medicine summit 3 in drug and biotechnology, 11 - 13 May 2017

BARX1 is down regulated in children with non syndromicsupernumerary teeth

the Ninth International Symposium on Dental Enamel: “Enamel 9”., 30 October - 03 November 2016

Pharmacogenomics and Pharmacomicrobiomics in Precision Medicine

24th Meeting of Balkan Clinical Laboratory Federation 4th Albanian National Conference of Laboratory Medicine, Albania, 5 - 07 October 2016

Personalized Medicine Pharmacotherapy Pharmacogenetics

International Conference on Science and Technology, Turkey, 3 - 06 October 2016

Innovations in Pharmacogenomics and Individualized Treatments

Tıpta İnovasyon Buluşmaları-2, Gaziantep, Turkey, 5 - 07 May 2016

Öngörüsel Tıp Uygulamasında Farmakogenetik

XII İÜGEN Uluslarası Katılımlı Moleküler Biyoloji ve Genetik Kış Okulu, 4 - 06 March 2016

Effects of Fluoxetine HCl on AML 12 Hepatocytes Proliferation by iCELLigence System

2nd IVEK International Convention of Pharmaceuticals and Pharmacies, Istanbul, Turkey, 27 - 29 November 2015

Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model

1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Turkey, 27 - 28 November 2015

The effects of stem cell therapy on CD68 FTO and RAN expression in fructose induced metabolic syndrome rat model for personalized therapy

1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Turkey, 27 - 28 November 2015

The role of Apolipoprotein B polymorphisms in essential hypertension

1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Turkey, 27 - 28 November 2015

The effects of cytotoxic agents over NIBAN gene expression and 3T3 L1 adipocyte proliferation

3rd ESPT Conference. Integration of Pharmacogenomics in Clinical Desicion Support, Hungary, 7 - 09 October 2015

The effects of oral antidiabetic drug metformin on liver metabolism by real time cell monitoring system

IFSO 20th World Congress. 20th World Congress of International Federation for the Surgery of Obesity&Metabolic Disorders, Austria, 26 - 29 August 2015

The Effects of Oxidative Stress Agents on FTO and CD68 gene expressions and free radical production in 3T3 L1 Adipocytes

International Symposium on Advancesin Predictive and Personalized Medicine “Bridging Nations in Istanbul: Personalized and Predictive Medicine in Turkey, Turkey, 2 - 03 April 2015

The effects of oral antidiabetic drug glipizide on liver metabolism by real time cell monitoring system

International Symposium on Advancesin Predictive and Personalized Medicine “Bridging Nations in Istanbul: Personalized and Predictive Medicine in Turkey, Turkey, 2 - 03 April 2015